Latest News

King Jim (TSE:7962) has put a stronger set of numbers on the table for Q2 2026, with revenue of ¥9.7b and basic EPS of ¥11.58 as net income reached ¥325.94m for the quarter. The company has seen quarterly revenue move around the ¥8.3b to ¥10.9b range over the past six reported periods, with basic EPS swinging from a loss of ¥10.63 in Q1 2026 to a profit of ¥11.58 in Q2 2026 after periods as low as a loss of ¥7.76 and as high as ¥16.49 since early 2025. This sets up a story where investors are...

If you are wondering whether Lamb Weston Holdings is attractively priced today, it helps to step back and look at what the recent share performance and fundamentals are really telling you about value. The stock last closed at US$45.96, with returns of 4.2% over the past 7 days, 9.6% over 30 days, 8.7% year to date, but a 22.9% decline over 1 year and a 49.7% decline over 3 years. This can change how investors think about its risk and return profile. Recent coverage of Lamb Weston has focused...

Woolworths Group (ASX:WOW) has refreshed its board, adding former Walmart and Google executive Jon Alferness as a non executive director, while Tracey Fellows plans to retire, spotlighting its digital and omnichannel priorities. See our latest analysis for Woolworths Group. Recent moves such as store upgrades and a focus on ecommerce sit alongside firmer price action, with Woolworths’ 90 day share price return of 8.91% outpacing its 5.31% 30 day gain, while the 3 year total shareholder return...

Daiichi Sankyo Company (TSE:4568) is back in focus after China approved ENHERTU as the first HER2 directed antibody drug conjugate for second line HER2 positive metastatic gastric cancer. This development spotlights its oncology pipeline alongside recent European regulatory progress. See our latest analysis for Daiichi Sankyo Company. Despite the positive headlines around ENHERTU and recent corporate updates, Daiichi Sankyo Company's share price has had a weak patch, with a 30 day share price...

Core (TSE:2359) has put up solid headline numbers for Q3 2026, with revenue of ¥7.0b and basic EPS of ¥63.26, while trailing 12 month EPS stands at ¥201.07 on revenue of ¥26.0b as earnings over that period grew 37.8% year over year. The company has seen revenue move from ¥6.0b in Q2 2025 to ¥6.7b in Q4 2025 and then to ¥7.0b in Q3 2026, with quarterly basic EPS stepping from ¥31.03 to ¥58.59 to ¥63.26 over the same points in time. With net margin at 11.1% over the last year versus 8.5% the...

In recent days, Jefferies downgraded Philip Morris International, citing mounting competitive pressure from British American Tobacco and Japan Tobacco in nicotine pouches and heated tobacco products despite Philip Morris International’s continued multibillion‑dollar US investment program since 2022. An interesting wrinkle is that this more cautious analyst stance arrives even as Philip Morris International maintains very strong gross margins and robust free cash flow generation,...

For investors wondering if Scotts Miracle-Gro at around US$65 a share still offers value, or if the easy money has already been made, this article is designed to address that question directly. The stock has recently posted returns of 5.0% over 7 days, 13.4% over 30 days and 10.1% year to date. However, the past 1 year, 3 year and 5 year returns of 4.8%, 11.5% and 67.1% declines present a different side of the story. These mixed returns reflect a period in which investors continue to...

Goodyear Tire & Rubber (NasdaqGS:GT) has joined a consolidated legal challenge against certain US tariffs, with the case now awaiting guidance from the Supreme Court. The company has also extended and expanded its sustainability focused partnership with TIP Group for five years, covering eco focused tire materials and service solutions across Europe. For investors watching Goodyear at a share price of $9.61, these developments add fresh context to a stock that has seen mixed multi year...

MannKind Corporation recently received FDA approval for an update to Afrezza’s Prescribing Information, refining recommended starting mealtime doses when adults switch from injected or pump-based insulin to the inhaled therapy, based on new modeling and clinical data. This label change is significant because clearer conversion guidance may influence how comfortably physicians transition suitable diabetes patients to Afrezza’s ultra rapid-acting inhaled insulin option, while keeping its known...

If you are wondering whether Evercore’s current share price still offers value, you are not alone. This article is set up to help you weigh what the market price might be implying. The stock last closed at US$355.91, with a 4.3% decline over the past 7 days, a 3.6% gain over 30 days, a 1.3% gain year to date, and a 24.4% gain over 1 year, compared with a very large 3 year return and a 238.9% return over 5 years. Recent coverage has focused on Evercore’s role in major advisory assignments and...

Engie (ENXTPA:ENGI) is back in focus after agreeing a 10 year biomethane purchase deal with PepsiCo UK, anchored by a new anaerobic digestion plant that will supply 60 GWh annually. See our latest analysis for Engie. These biomethane and recent solar announcements arrive during a strong run for Engie’s shares, with a 12.0% 1 month and 23.6% 3 month share price return, while the 1 year total shareholder return of 71.3% and 5 year total shareholder return of 175.0% point to momentum that has...

Nankai Electric Railway (TSE:9044) has put up a clean set of Q3 2026 numbers, with revenue of ¥68,876 million and net income of ¥8,174 million translating into basic EPS of ¥74.9. The company has seen revenue move from ¥63,535 million in Q3 2025 to ¥68,876 million in Q3 2026, while basic EPS has gone from ¥67.7 to ¥74.9 over the same period, giving investors a fuller picture of how the top line and EPS have tracked together. With a trailing net profit margin sitting around 9.1%, the latest...

Intrum (OM:INTRUM) closed out FY 2025 with fourth quarter revenue of SEK 4,493 million and Basic EPS of SEK 16.68 loss, rounding off a year in which trailing twelve month revenue stood at SEK 17,030 million and Basic EPS was SEK 11.25 loss. Over the past few reported quarters, revenue has moved from SEK 4,825 million in Q4 2024 to SEK 4,056 million in Q3 2025 and SEK 4,493 million in Q4 2025. Quarterly Basic EPS has ranged from SEK 7.58 loss in Q4 2024 to SEK 3.00 in Q3 2025 and SEK 16.68...

Hogy MedicalLtd (TSE:3593) has posted Q3 2026 results with revenue of ¥9,862 million and basic EPS of ¥24.63, alongside net income of ¥531 million. The company has seen quarterly revenue move from ¥9,894 million in Q2 2025 to ¥9,862 million in Q3 2026, while basic EPS shifted from ¥39.00 to ¥24.63 over the same span, with net income moving from ¥861 million to ¥531 million. This keeps the focus squarely on how efficiently that revenue is turning into profit. See our full analysis for Hogy...

The Charles Schwab Corporation’s Board of Directors has approved a 5 cent, or 19%, increase in its regular quarterly cash dividend to US$0.32 per common share, payable on February 27, 2026 to stockholders of record on February 13, 2026. This higher dividend, coming soon after strong 2025 earnings and a multi-billion-dollar share repurchase program, highlights Schwab’s continued emphasis on returning capital to shareholders. We’ll now examine how this sizable dividend hike, alongside recent...

FireFly Metals has reported a very large 51% upgrade to the Green Bay Mineral Resource in Newfoundland and completed an approximately A$149,000,000 equity raising to fund drilling, economic studies and project advancement. This upgrade has defined a high-grade core and brought forward economic and development work, with a Preliminary Economic Assessment and Feasibility Study now targeted for completion in 2026. We will now examine how the enlarged Green Bay resource and accelerated...

Greif (NYSE:GEF) approved a new $300 million share repurchase authorization. The company reported leverage at historically low levels after recent debt reduction efforts. Greif plans to sell a timberland portfolio, with proceeds expected to be used for further debt reduction. Greif, a global producer of industrial packaging and related services, operates at the intersection of manufacturing, logistics, and materials handling, areas that often track broader industrial activity. For...

Kimura Unity Q3 2026 earnings snapshot Kimura Unity (TSE:9368) has put fresh numbers on the table for Q3 2026, posting revenue of ¥17.0 billion and net income of ¥1,248 million, which translated into basic EPS of ¥30.35. The company has seen revenue move from ¥15.5 billion in Q3 2025 to ¥17.0 billion in Q3 2026, with EPS shifting from ¥24.74 to ¥30.35 over the same period, while trailing twelve month EPS came in at ¥87.11 on revenue of ¥62.9 billion. With net profit margins running at 5.7%...

Chevron (NYSE:CVX) is reporting strong quarterly operations alongside record oil and gas production. The company is planning a 50% increase in Venezuelan output, supported by recent US policy changes and a special Treasury license. Chevron is the only US operator active in Venezuela under this framework, and is also working on integrating Hess assets. Key project milestones in regions such as Kazakhstan and the Eastern Mediterranean are being reached as part of a broader expansion...

Despite an already strong run, Australis Oil & Gas Limited ( ASX:ATS ) shares have been powering on, with a gain of 40...

Wesdome Gold Mines (TSX:WDO) has paired a record exploration budget with fresh 2026 production guidance and full year 2025 results, along with an interim COO appointment that reshapes its operational leadership. See our latest analysis for Wesdome Gold Mines. Despite a 2.9% 1 day share price decline and a softer 7 day share price return of 5.8%, Wesdome Gold Mines still shows a 6.1% 1 month and 15.3% 3 month share price gain, alongside a 1 year total shareholder return of 67.6% and a 3 year...

Mirai IndustryLtd (TSE:7931) reported Q3 2026 revenue of ¥12.4b and basic EPS of ¥100.07. For recent quarterly context, revenue was ¥11.3b in Q2 2026 and ¥10.1b in Q4 2025, while EPS moved from ¥72.00 to ¥54.95 over those same quarters. The company’s trailing twelve month EPS was ¥290.97 and revenue was ¥45.5b, framing this quarter’s results within a year in which net margin moved from 11.3% to 10.3%, leaving investors to weigh the revenue and EPS figures against slightly softer...

In January 2026, Uranium Energy Corp. presented at the Vancouver Resource Investment Conference shortly after President Trump announced new U.S. policies to streamline nuclear reactor licensing and bolster the domestic nuclear fuel supply chain. This alignment between a policy push for nuclear energy and Uranium Energy’s U.S.-focused production and inventory footprint has sharpened attention on the company’s role in reinforcing domestic fuel security. Against this backdrop, we’ll examine...

Wondering if Alnylam Pharmaceuticals at around US$346 is offering you fair value or asking too much? This article walks through the key numbers that matter for investors focused on price versus value. The stock has pulled back recently, with a 6.3% decline over the last 7 days and a 12.7% decline over the past 30 days, although the 1 year return sits at 25.1% and the 5 year return at 119.6%. Recent attention on Alnylam Pharmaceuticals has centred on its broader pipeline and commercial...